Part 7 for May 2017 (Uploaded 28/4/2017)
Epilepsy indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
Generalised Anxiety Disorder Indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Neuropathic Pain Lyrica (Pfizer) is the only product that may be dispensed for this indication.
Pfizer’s patent on Pregabalin for use in the treatment of neuropathic pain is currently in place until July 2017
Please check the Shortages page for any adjustments to prices during the month.
Category F - A fixed price set in line with the revised Scottish protocol.
Category M - Applies to items added to Part 7 from October 2010 where the reimbursement price is calculated by the department of Health using information submitted by manufacturers.
Category R - This category was added in October 2010.
Category Z - Zero Discount items.
The most recent Discount Clawback Rates are available to download.
Part 7B (from 08/09/2016)
This section has been developed in order to clarify the pricing of certain items when prescribed generically on CP2 forms.
Part 7S (Updated 28/4/2017)
For unlicensed and imported medicines not contained within Part 7S of the drug tariff, please see the circular and supporting documents below.
Prescriptions should be endorsed both electronically and on paper with the special price, fixed non-part 7s handling charge and any other expenses. We have recently seen a number of items where these endorsements have not been applied electronically. Where this is the case, Practitioner Services will not allocate fees if electronic information is used for payment.
If you have any further questions regarding this, please do not hesitate to contact the Pharmacy Services team on 0131 4663540.
Part 7U List (Updated 28/4/2017)
After consultation with CPS, the Scottish Government has introduced a new section to the Drug Tariff — Part 7U. See circular PCA(P)(2013)32 for more details. This new section lists pack sizes and prices for products without a formal marketing authorisation which are available. The new section has been introduced to facilitate transparent reimbursement of the costs of these products. It will also remove any need to seek authorisation from the NHS Board before these products are supplied.
The Drug Tariff Amendments relate to the Scottish Drug Tariff Amendments, Price Amendments and Stoma Amendments.
Download a copy of the April 2017 Drug Tariff Amendments.